Patent ID: 11873303
Assignee: MERCK PATENT GMBH
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The method of claim 10, wherein the patient has an interleukin-1 receptor associated kinase-mediated disorder selected from the group consisting of adult onset Still's disease, Alzheimer's disease, ankylosing spondylitis, atherosclerosis, Castleman's disease, celiac disease, a ciyopyrin-associated periodic syndrome, deficiency of interleukin-1 receptor antagonist (DIRA), endometriosis, gout, hyperimmunoglobulinemia D and periodic fever syndrome, inflammatory bowel disease, lupus nephritis, multiple sclerosis, osteoarthritis, osteoporosis, Parkinson's disease, pseudogout, psoriasis, psoriatic arthritis, rheumatoid arthritis, synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, Schnitzler's syndrome, sepsis, stroke, systemic lupus erythematosus, systemic juvenile idiopathic arthritis, systemic sclerosis, type I diabetes, and type II diabetes.